Impact of Label Restriction on Checkpoint-Inhibitor Use in Bladder Cancer and Changes in Mortality
JNCI Cancer Spectrum
Authors
Daniel T. Vader, Ravi B. Parikh, Haojie Li, Kentaro Imai, Rebecca A. Hubbard, Ronac Mamtani
CHIBE Experts
Research Areas
You might also be interested in...
View all publications-
Obesity Prevention at an Early Age: Progress, but a Long Way to Go
JAMANovember 21, 2024 -
Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices
Forum for Health Economics and PolicyNovember 8, 2024 -
Handheld Cellphone Use and Risky Driving in Adolescents
JAMA NetworkOctober 17, 2024 -
Real-Time Prescription Benefit Tool Adoption Among US Hospitals
JAMA Health ForumOctober 4, 2024 -
Implementation of a Secure Firearm Storage Program in Pediatric Primary Care: A Cluster Randomized Trial
JAMA PediatricsSeptember 19, 2024 -
Machine learning approach to investigate pregnancy and childbirth risk factors of sleep problems in early adolescence: Evidence from two cohort studies
Computer Methods and Programs in BiomedicineAugust 28, 2024 -
Protocol for a type 3 hybrid implementation cluster randomized clinical trial to evaluate the effect of patient and clinician nudges to advance the use of genomic medicine across a diverse health system
Implementation ScienceAugust 19, 2024 -
Efficacy of a Mobile App-Based Intervention for Young Adults With Anxiety Disorders: A Randomized Clinical Trial
JAMA NetworkAugust 1, 2024 -
Investigating racial and gender disparities in virtual randomized clinical trial enrollment: Insights from the BE ACTIVE study
American Heart JournalJuly 30, 2024 -
A randomized trial of behavioral interventions yielding sustained reductions in distracted driving
PNASJuly 29, 2024 -
Feedback and Financial Incentives for Reducing Cell Phone Use While Driving
JAMA NetworkJuly 10, 2024 -
Effect of a Smartphone App (S-Check) on Actual and Intended Help-Seeking and Motivation to Change Methamphetamine Use Among Adult Consumers of Methamphetamine in Australia: Randomized Waitlist-Controlled Trial
JMIRJuly 3, 2024